Creative Planning
ENTA icon

Creative Planning’s Enanta Pharmaceuticals ENTA Stock Holding History

Creative Planning’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Buy
+12,245
New +$164K ﹤0.01% 3805
2016
Q1 		– Sell
-37
Closed -$1K – 4370
2015
Q4 		$1K Hold
37
– – ﹤0.01% 4196
2015
Q3 		$1K Buy
+37
New +$1.59K ﹤0.01% 4083
2015
Q1 		– Sell
-374
Closed -$19K – 4260
2014
Q4 		$19K Sell
374
-481
-56% -$21.5K ﹤0.01% 2686
2014
Q3 		$34K Buy
+855
New +$34.1K ﹤0.01% 2175
2014
Q2 		– Sell
-706
Closed -$28K – 3816
2014
Q1 		$28K Sell
706
-912
-56% -$33.1K ﹤0.01% 2173
2013
Q4 		$44K Buy
1,618
+1,076
+199% +$26.1K ﹤0.01% 1685
2013
Q3 		$12K Buy
+542
New +$10.4K ﹤0.01% 2351

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Creative Planning's ENTA Position: Q1 2026 in Review

Creative Planning opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 12,245 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #3805 among its holdings. This is a return to the name: Creative Planning previously reported a position in ENTA as recently as Q4 2015.

Creative Planning first reported a position in ENTA in Q3 2013 and has held it in 8 quarters since. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Creative Planning held 12,245 shares of Enanta Pharmaceuticals worth $155K as of Q1 2026.
  • Enanta Pharmaceuticals was a new Creative Planning position in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3805 holding.
  • Creative Planning first reported a position in Enanta Pharmaceuticals in Q3 2013 and has held it in 8 quarters since.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.